Helper Functions Required for Wild Type and Recombinant Adeno- Associated Virus Growth

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|5|3|265-271

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.5, Iss.3, 2005-06, pp. : 265-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biosafety of Recombinant Adeno-associated Virus Vectors

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-01 ,pp. : 434-452

Bentham Science Publishers

Access to resources Recommend Favorite

Immunogenic Issues Concerning Recombinant Adeno-Associated Virus Vectors for Gene Therapy

By  

Current Gene Therapy, Vol. 2, Iss. 4, 2002-01 ,pp. : 485-500

Bentham Science Publishers

Access to resources Recommend Favorite

Restriction Factors Against Recombinant Adeno-associated Virus Vectormediated Gene Transfer in Dystrophin-deficient Muscles

By  

Current Gene Therapy, Vol. 16, Iss. 3, 2016-06 ,pp. : 168-183

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Recombinant Adeno-Associated Virus: Current Achievements and Limitations (Guest Editor: Philippe Moullier)]

By  

Current Gene Therapy, Vol. 5, Iss. 3, 2005-06 ,pp. : 263-263

Bentham Science Publishers

Access to resources Recommend Favorite

Scalable Downstream Strategies for Purification of Recombinant Adeno- Associated Virus Vectors in Light of the Properties

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 8, 2015-01 ,pp. : 684-695

Bentham Science Publishers

Access to resources Recommend Favorite